NBHAX
Price
$15.14
Change
+$0.01 (+0.07%)
Updated
Oct 17 closing price
Net Assets
973.05M
VIVIX
Price
$72.41
Change
+$0.36 (+0.50%)
Updated
Oct 17 closing price
Net Assets
207.8B
Interact to see
Advertisement

NBHAX vs VIVIX

Header iconNBHAX vs VIVIX Comparison
Open Charts NBHAX vs VIVIXBanner chart's image
Neuberger Berman Equity Income A
Price$15.14
Change+$0.01 (+0.07%)
VolumeN/A
Net Assets973.05M
Vanguard Value Index I
Price$72.41
Change+$0.36 (+0.50%)
VolumeN/A
Net Assets207.8B
NBHAX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
NBHAX vs. VIVIX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBHAX is a Hold and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 208B vs. NBHAX (973M). VIVIX pays higher dividends than NBHAX: VIVIX (2.09) vs NBHAX (1.62). NBHAX was incepted earlier than VIVIX: NBHAX (17 years) vs VIVIX (27 years). NBHAX (1.09) is less costly to investors than VIVIX (0.04). NBHAX is a more actively managed with annual turnover of: 28.00 vs. VIVIX (9.00). NBHAX has a lower initial minimum investment than VIVIX: NBHAX (1000) vs VIVIX (5000000). NBHAX annual gain was more profitable for investors over the last year : 5.71 vs. VIVIX (4.12). VIVIX return over 5 years is better than : 70.92 vs. NBHAX (30.18).
NBHAXVIVIXNBHAX / VIVIX
Total Expense Ratio1.090.042,725%
Annual Report Gross Expense Ratio1.090.042,725%
Fund Existence17 years27 years-
Gain YTD15.2529.202166%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets973M208B0%
Annual Yield % from dividends1.622.0977%
Returns for 1 year5.714.12138%
Returns for 3 years24.7142.2758%
Returns for 5 years30.1870.9243%
Returns for 10 years45.84128.2636%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN24.211.20
+5.22%
Viridian Therapeutics
BZ21.670.17
+0.81%
Kanzhun Limited
NHPAP17.84N/A
N/A
National Healthcare Properties Inc
CCRN12.62-0.23
-1.79%
Cross Country Healthcare
LICN4.17-0.18
-4.14%
Lichen International Limited